Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Pooled safety summary for patients treated with the CD22-directed cytotoxi n moxetumomab pasudotox-tdfk. Kreitman, R. J., Coutre, S., Elesinmogun, C., Kuptsova-Clarkson, N., Li, X., Pastan, I., Gladstone, D. AMER SOC CLINICAL ONCOLOGY. 2019
View details for Web of Science ID 000487345806217